Answer
Omnipaque (iohexol), whose safety in human pregnancy is unestablished, may be used only when the benefit outweighs the risk and the physician considers it essential, accounting for radiation exposure, which should be avoided whenever possible, and foetal thyroid sensitivity to iodine.
Sources for this answer
- Omnipaque Injection 300mg I/ml solution for injectionGE Healthcare Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked